ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Ascendant Resources Inc

Ascendant Resources Inc (ASND)

0.05
0.005
(11.11%)
Closed December 21 3:12PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.05
Bid
0.045
Ask
0.05
Volume
20,000
0.05 Day's Range 0.05
0.03 52 Week Range 0.085
Market Cap
Previous Close
0.045
Open
0.05
Last Trade
11000
@
0.05
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
103,427
Shares Outstanding
160,972,000
Dividend Yield
-
PE Ratio
-1.04
Earnings Per Share (EPS)
-0.05
Revenue
-
Net Profit
-7.76M

About Ascendant Resources Inc

Sector
Crude Petroleum & Natural Gs
Industry
Business Services, Nec
Headquarters
Toronto, Ontario, Can
Founded
2009
Ascendant Resources Inc is listed in the Crude Petroleum & Natural Gs sector of the Toronto Stock Exchange with ticker ASND. The last closing price for Ascendant Resources was $0.05. Over the last year, Ascendant Resources shares have traded in a share price range of $ 0.03 to $ 0.085.

Ascendant Resources currently has 160,972,000 shares outstanding. The market capitalization of Ascendant Resources is $7.24 million. Ascendant Resources has a price to earnings ratio (PE ratio) of -1.04.

ASND Latest News

ASCENDANT ANNOUNCES APPOINTMENT OF MR. VAL COETZEE AS DIRECTOR OF PROCESS ENGINEERING

ASCENDANT ANNOUNCES APPOINTMENT OF MR. VAL COETZEE AS DIRECTOR OF PROCESS ENGINEERING Canada NewsWire TORONTO, Oct. 16, 2023 TSX: ASNDwww.ascendantresources.com Appointment of Highly Experienced...

ASCENDANT RESOURCES ENTERS TENDER PHASE FOR MANDATED LEAD ARRANGER FOR ITS EXPORT CREDIT AGENCY SUPPORTED PROJECT FINANCING AT ITS LAGOA SALGADA PROJECT IN PORTUGAL

ASCENDANT RESOURCES ENTERS TENDER PHASE FOR MANDATED LEAD ARRANGER FOR ITS EXPORT CREDIT AGENCY SUPPORTED PROJECT FINANCING AT ITS LAGOA SALGADA PROJECT IN PORTUGAL PR Newswire TORONTO, Sept. 5...

Ascendant Resources Announces Results of Annual and Special Meeting of Shareholders

Ascendant Resources Announces Results of Annual and Special Meeting of Shareholders Canada NewsWire TORONTO, Aug. 23, 2023 TSX: ASNDwww.ascendantresources.com All matters overwhelmingly approved...

ASCENDANT RESOURCES EARNS 80% INTEREST IN THE LAGOA SALGADA PROJECT IN PORTUGAL AND FILES FEASIBILITY STUDY

ASCENDANT RESOURCES EARNS 80% INTEREST IN THE LAGOA SALGADA PROJECT IN PORTUGAL AND FILES FEASIBILITY STUDY Canada NewsWire TORONTO, Aug. 1, 2023 TSX: ASNDwww.ascendantresources.com •  PROJECT...

ASCENDANT RESOURCES ANNOUNCES POST-TAX NPV8 OF US$147 MILLION AND 39% IRR FROM INITIAL FEASIBILITY STUDY AT ITS LAGOA SALGADA PROJECT IN PORTUGAL

ASCENDANT RESOURCES ANNOUNCES POST-TAX NPV8 OF US$147 MILLION AND 39% IRR FROM INITIAL FEASIBILITY STUDY AT ITS LAGOA SALGADA PROJECT IN PORTUGAL Canada NewsWire TORONTO, July 25, 2023...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.00511.11111111110.0450.050.04558340.045CS
40.01250.040.050.03778130.04361138CS
120.01250.040.060.031034270.04465596CS
260.01250.040.060.03782210.04435812CS
52-0.035-41.17647058820.0850.0850.03794120.05337315CS
156-0.15-750.20.2950.03714480.12545834CS
260-0.22-81.48148148150.270.410.03808940.1539804CS

ASND - Frequently Asked Questions (FAQ)

What is the current Ascendant Resources share price?
The current share price of Ascendant Resources is $ 0.05
How many Ascendant Resources shares are in issue?
Ascendant Resources has 160,972,000 shares in issue
What is the market cap of Ascendant Resources?
The market capitalisation of Ascendant Resources is CAD 7.24M
What is the 1 year trading range for Ascendant Resources share price?
Ascendant Resources has traded in the range of $ 0.03 to $ 0.085 during the past year
What is the PE ratio of Ascendant Resources?
The price to earnings ratio of Ascendant Resources is -1.04
What is the reporting currency for Ascendant Resources?
Ascendant Resources reports financial results in USD
What is the latest annual profit for Ascendant Resources?
The latest annual profit of Ascendant Resources is USD -7.76M
What is the registered address of Ascendant Resources?
The registered address for Ascendant Resources is 110 YONGE STREET, SUITE 501, TORONTO, ONTARIO, M5C 1T4
What is the Ascendant Resources website address?
The website address for Ascendant Resources is www.ascendantresources.com
Which industry sector does Ascendant Resources operate in?
Ascendant Resources operates in the BUSINESS SERVICES, NEC sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
APSAptose Biosciences Inc
$ 0.42
(75.00%)
30.28k
RTGRTG Mining Inc
$ 0.04
(60.00%)
3k
BNGBengal Energy Ltd
$ 0.015
(50.00%)
1,000
BBBlackBerry Limited
$ 5.29
(23.60%)
13.59M
ARAAclara Resources Inc
$ 0.495
(17.86%)
27.19k
BABYElse Nutrition Holdings Inc
$ 0.01
(-33.33%)
190k
DIAMStar Diamond Corporation
$ 0.015
(-25.00%)
2.34M
KRNKarnalyte Resources Inc
$ 0.085
(-19.05%)
20.5k
STEPSTEP Energy Services Ltd
$ 4.18
(-14.87%)
283.69k
SBISerabi Gold Plc
$ 2.13
(-11.62%)
73.81k
CNQCanadian Natural Resources Ltd
$ 42.49
(0.02%)
18.71M
TRPTC Energy Corporation
$ 65.77
(0.84%)
17.86M
CMCanadian Imperial Bank of Commerce
$ 92.48
(0.75%)
16.28M
MFCManulife Financial Corporation
$ 43.54
(0.48%)
14.47M
BBBlackBerry Limited
$ 5.29
(23.60%)
13.59M

ASND Discussion

View Posts
Monksdream Monksdream 10 months ago
ASND new 52=week high
👍️0
Monksdream Monksdream 10 months ago
ASND new 52 week high
👍️0
MiamiGent MiamiGent 10 months ago
What goes down, must go up :)
Hope you banked, monk.
👍️0
Monksdream Monksdream 10 months ago
ASND new 52 week high
👍️0
Monksdream Monksdream 11 months ago
ASND new 52 week high
👍️0
MiamiGent MiamiGent 2 years ago
ASND 161 shares traded in pre-mkt. Take your profits- nobody going to hold up this dilution candidate.
Bearish
👍️0
MiamiGent MiamiGent 2 years ago
ASND After just one day of wooing, ASND is FALLING ...........in love with my short.
Irresistible attraction: fourteen-month delay on average, need for more money and a red market with housing assuring further rate increase.
Quote as of 5/02/2023 2:44PM ET
$86.375 -$0.365 (-0.421%)
Bearish
https://www.bing.com/videos/search?q=you+tube+music+roy+orbison+i%27m+falling&view=detail&mid=17436B40AE02F042D00317436B40AE02F042D003&FORM=VIRE
👍️0
MiamiGent MiamiGent 2 years ago
$ASND
A complete response letter (CRL) from the FDA delays a product’s entry to the market by an average of 14 months. Companies that receive the letters take an average of seven months just to respond to them.
FDA NEWS
Bearish
👍️0
MiamiGent MiamiGent 2 years ago
ASND Net Income -$622,419,000 in 2022

Anyone want to venture a guess when the raise will come?

I'll take a WAG and say within two weeks.
👍️0
MiamiGent MiamiGent 2 years ago
ASND Quote as of 5/02/2023 10:14AM ET

$88.07 +$1.33 (+1.533%)

I'm down -3.22% on my short. Did not choose well- 100% owned by institutions.. not easily budged.
I am counting on red days, 3 day rule, CRL and outside chance of a raise- it's all I got, lol

https://stockcharts.com/h-sc/ui?s=ASND
👍️0
MiamiGent MiamiGent 2 years ago
Short today at 85.34

How long will this languish before possible good news?

Will need to raise more $$
👍️0
crudeoil24 crudeoil24 3 years ago
Ascendis Pharma: FDA Approves Skytrofa to Treat Pediatric Growth Hormone Deficiency > ASND
3:46 pm ET August 25, 2021

By Stephen Nakrosis

Ascendis Pharma A/S on Wednesday said the U.S. Food and Drug Administration approved its Skytrofa as a treatment for Pediatric Growth Hormone Deficiency.

The company said Skytrofa, or lonapegsomatropin-tcgd, is the first once-weekly treatment approved to treat Pediatric Growth Hormone Deficiency.

The company also said Skytrofa was approved to treat "pediatric patients one year and older who weigh at least 11.5 kg and have growth failure due to inadequate secretion of endogenous growth hormone."

The company said the approval includes its Skytrofa Auto-Injector and cartridges, which enable families to store the medicine at room temperature for up to six months.

The company said availability of Skytrofa in the U.S. is expected soon.

Ascendis said it would hold an investor conference call at 4:30 p.m. ET today.


Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
👍️0
crudeoil24 crudeoil24 3 years ago

ASCENDIS PHARMA A/S is a Danish-based biopharmaceutical company, which is involved in manufacture products for rare diseases. The Company utilizes its TransCon technologies for treatment, which can be applied to existing drug therapies, including proteins, peptides and small molecules, to create prodrugs. The Company is headquartered in Copenhagen, Denmark with offices in Heidelberg, Germany and Palo Alto, California.
👍️0

Your Recent History

Delayed Upgrade Clock